EP0955035A1 | 1999-11-10 | |||
US4668419A | 1987-05-26 | |||
US4589994A | 1986-05-20 | |||
DE10140538A1 | 2003-03-06 | |||
FR2762008A1 | 1998-10-16 | |||
FR2720643A1 | 1995-12-08 | |||
ZA983753B | 2000-01-26 | |||
ZA982679B | 1999-12-29 | |||
JPH06100412A | 1994-04-12 | |||
RU2127581C1 | 1999-03-20 |
Pongamia, as used herein, is an essential oil extracted by means of steam distillation from the Karanji Seed. The original plant comes from India, has the botanical Name Pongamia Pinnata, and the extract works as a pH reducer. Tagettes, as used herein, is an essential oil extracted from the Tagettes Minυta plant. It works as a bacteria growth inhibitor. The manufacturing process starts with the preparation of a first partial mix containing Pongamia, Tagettes, basilicum oil and ionized water into a sterilized plastic tank. This first partial mix is stirred for 4 and a half hours at 35-45 RPM under a constant temperature of 450C. This first partial mix is collected into a sterilized plastic container, which is then sealed for 10 days and shaken periodically three times a day for 3 minutes at a time. A second partial mix is the prepared with the remaining ingredients (clover oil, garlic oil, eucalyptus oil, citrus oil and oregano dialyma) mixed in a sterilized plastic tank. This second partial mix is stirred for 3 hours at 35-45 RPM under a constant temperature of 39°C. This second partial mix is collected into a sterilized plastic container, which is then sealed for 10 days and shaken periodically three times a day for 3 minutes at a time, exactly like the first partial mix. At the end of the 10-day long period both containers are opened and their contents are added together to form the final mix, to which are added Vitamins Bl, B2, B3, B4, C, Fe, Mn (0.02 to 0.04 % of the total mass for each one), mixing this final mix constantly at 35-45 RPM for 5 hours while slowly- adding the peppermint oil (0.01 to 0.08 % of the total mass) and PEG-40 stabilizer (0.35 to 0.50 % of the total mass). PERFORMANCE ASSESSMENT The mixture described has the property of hampering the development of the microorganisms associated with foot odor. In view of the subjectivity inherent to an analysis such as that of foot odor before and after the application of a suitable product containing the composition of the present invention, a thorough study has been carried out by a reputed institute (Inveresk Research of Scotland) in order to assess it's degree of efficacy over a four month period. The study contemplated both quantitative aspects (viable counts of microorganisms) and qualitative aspects (questionnaires answered by the studied individuals) . Test Materials The following test materials were received at Inveresk on 7 and 21 January 2003 and were stored in the dark under ambient conditions.
An expiry date of August 2005 was supplied by the Sponsor. Skin pH Determination The pH of the foot sole was recorded using a surface pH electrode after application of 0.1 ml water. Foot Odour Assessments Foot odour was assessed according to the following scale. A Study to Assess the Efficacy of Saturated Wipes Table 1 Odour Score Recorded
Table 1 (continued) Odour Score Recorded
A Study to Assess the Efficacy of Saturated Wipes Table 2 pH Score Recorded
Table 2 (continued) pH Score Recorded
A Study to Assess the Efficacy of Saturated Wipes Table 3 Viable Count of Staphylococci
A Study to Assess the Efficacy of Saturated Wipes Table 4 Yeasts/Fungi Viable Counts
A Study to Assess the Efficacy of Saturated Wipes Table 5 Micrococci Viable Counts (cfu/ml)
The results on the 53 individuals that took part in the study clearly indicates a remarkable difference before and after the application of the invention' s composition on their feet. After two months, not only the subjective analysis indicated that the odor has been dramatically reduced, but also the quantitative analysis yielded a reduction of viable counts of the microorganisms that cause foot odor. The timeline extension of the study demonstrates that the product's efficiency is not fleeting, with still remarkable reductions of microorganism counting at the end of the two month long study. There were no collateral effects for the skin and no interference with the normal physiologic process of sweating. INDUSTRIAL APPLICABILITY The composition of the present invention is easily reproducible through the corresponding, specific manufacturing process and can be applied by means of gel, creams, lotions, patches, inner parts of shoes in genneral and insoles (inner soles) . Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only, being the true scope of the invention indicated by the following claims.
Next Patent: A DEVICE FOR FASTENING PASSENGER SEATS ON A SEAT TRACK BREAK IN AN AIRCRAFT